Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis - Related Studies

Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis

This study has been completed.

Study NCT00004794. Last updated on June 23, 2005. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cytomegalovirus Retinitis
		Acquired Immunodeficiency Syndrome

2	Additional conditions recognized in this trial
		Cytomegalovirus Infections
		HIV Infections
		Immunologic Deficiency Syndromes
		Retinitis
		Syndrome

3	More general conditions related to this trial
		Disease
		DNA Virus Infections
		Eye Diseases
		Eye Infections
		Eye Infections, Viral
		Herpesviridae Infections
		Immune System Diseases
		Lentivirus Infections
		Pathologic Processes
		Retinal Diseases
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		cidofovir

5	More general drug interventions related to this trial
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Retroviral Agents
		Antineoplastic Agents
		Antiviral Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Center for Research Resources (NCRR)
		Northwestern University